CLINICAL_TRIALS
trial_result
· 2021-07-20
Clinical Trial Update: An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis [Phase 2]
Summary
Phase 2 exploratory study of rebamipide in patients with active ulcerative colitis has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2021-07-20